Parametric Portfolio Associates’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$100K Sell
14,133
-2,931
-17% -$24.2K ﹤0.01% 3562
2021
Q4
$310K Buy
17,064
+6,802
+66% +$147K ﹤0.01% 3279
2021
Q3
$201K Sell
10,262
-2,038
-17% -$77.5K ﹤0.01% 3442
2021
Q2
$551K Buy
+12,300
New +$570K ﹤0.01% 3044
2021
Q1
Sell
-3,539
Closed -$316K 4093
2020
Q4
$316K Buy
+3,539
New +$298K ﹤0.01% 3576

Other funds holding CELL

Parametric Portfolio Associates's CELL Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its PhenomeX Inc. Common Stock (CELL) stake by 17% in Q1 2022, selling an estimated $24.2K and leaving 14,133 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #3562.

Parametric Portfolio Associates first reported a position in CELL in Q4 2020 and has held it in 5 quarters since. The position peaked at $551K in Q2 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

  • Parametric Portfolio Associates held 14,133 shares of PhenomeX Inc. Common Stock worth $100K as of Q1 2022.
  • Parametric Portfolio Associates sold 2,931 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $24.2K.
  • PhenomeX Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3562 holding.
  • Parametric Portfolio Associates first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and has held it in 5 quarters since.
  • Parametric Portfolio Associates's PhenomeX Inc. Common Stock position peaked at $551K in Q2 2021.
  • 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.